Show
Sort by
-
An allometric model of remifentanil pharmacokinetics and pharmacodynamics
-
A new pharmacokinetic model of propofol: effect of age on clearance and impact of the terminal distribution phase: response
-
A general purpose pharmacokinetic model for propofol
-
- Journal Article
- A1
- open access
A response surface model approach for continuous measures of hypnotic and analgesic effect during sevoflurane-remifentanil interaction: quantifying the pharmacodynamic shift evoked by stimulation
-
Dopamine D2 receptor occupancy as a predictor of catalepsy in rats: a pharmacokinetic-pharmacodynamic modeling approach
-
Modelling and simulation of placebo effect: application to drug development in schizophrenia
-
Interaction between nitrous oxide, sevoflurane, and opioids: a response surface approach
-
Sensitivity of individual items of the Positive and Negative Syndrome Scale (PANSS) and items subgroups to differentiate between placebo and drug treatment in schizophrenia
-
Pharmacokinetic-pharmacodynamic modeling of antipsychotic drugs in patients with schizophrenia, part I: the use of PANSS total score and clinical utility
-
Pharmacokinetic-pharmacodynamic modelling of antipsychotic drugs in patients with schizophrenia, part II: the use of subscales of the PANSS score